Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Risk of intra-abdominal seeding after laparoscopic-assisted thermal ablation of exophytic hepatocellular carcinoma tumors.

  • Authors : Garbarine IC; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.; Gerber DA

Subjects: Abdominal Cavity*/Abdominal Cavity*/Abdominal Cavity*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery

  • Source: Surgical endoscopy [Surg Endosc] 2022 Oct; Vol. 36 (10), pp. 7569-7576. Date of Electronic Publication: 2022 Mar 29.Publisher: Springer Country of Publication: Germany NLM ID: 8806653 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.

  • Authors : Tang Q; Department of Pharmacology, School of Pharmacy, China Medical University, Heping Ward, Shenyang City, 110001, Liaoning Province, People's Republic of China, .; Zhao Y

Subjects: Chemoembolization, Therapeutic*/Chemoembolization, Therapeutic*/Chemoembolization, Therapeutic*/methods; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*genetics

  • Source: Medical oncology (Northwood, London, England) [Med Oncol] 2014 Nov; Vol. 31 (11), pp. 267. Date of Electronic Publication: 2014 Oct 01.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Laparoscopically Limited Anatomic Liver Resections: A Single-Center Analysis for Oncologic Outcomes of the Conceptual Procedure.

  • Authors : Wakabayashi T; Center for Advanced Treatment of Hepatobiliary and Pancreatic Diseases, Ageo Central General Hospital, Ageo, Saitama, Japan. .; Fujiyama Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/secondary ; Laparoscopy*/Laparoscopy*/Laparoscopy*/methods

  • Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Feb; Vol. 31 (2), pp. 1243-1251. Date of Electronic Publication: 2023 Nov 10.Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma.

  • Authors : Massarweh NN; Department of Surgery, University of Washington, Seattle, WA, USA. ; Park JO

Subjects: Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*mortality ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*surgery ; Catheter Ablation/Catheter Ablation/Catheter Ablation/*statistics & numerical data

  • Source: Annals of surgical oncology [Ann Surg Oncol] 2012 Apr; Vol. 19 (4), pp. 1058-65. Date of Electronic Publication: 2011 Sep 27.Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort Study.

  • Authors : Liu F; Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.; Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province, Wuhan, Hubei, People's Republic of China.

Subjects: Carcinoma, Hepatocellular* ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; Laparoscopy*/Laparoscopy*/Laparoscopy*/methods

  • Source: Annals of surgical oncology [Ann Surg Oncol] 2023 Apr; Vol. 30 (4), pp. 1991-2002. Date of Electronic Publication: 2023 Jan 16.Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study.

  • Authors : Patwala K; Department of Gastroenterology, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia. .; Prince DS

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Hypertension*/Hypertension*/Hypertension*/chemically induced ; Hypertension*/Hypertension*/Hypertension*/drug therapy

  • Source: Hepatology international [Hepatol Int] 2022 Oct; Vol. 16 (5), pp. 1170-1178. Date of Electronic Publication: 2022 Aug 25.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study.

  • Authors : Chen YG; Division of Hematology/Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.; Cancer Institute, University College London, London, UK.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/complications ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/etiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/complications

  • Source: Hepatology international [Hepatol Int] 2022 Aug; Vol. 16 (4), pp. 807-816. Date of Electronic Publication: 2022 Jan 22.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Selective serotonin reuptake inhibitors use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.

  • Authors : Bhagavathula AS; Department of Social and Clinical Pharmacy, Faculty of Pharmacy at Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. .; Woolf B

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/chemically induced ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/epidemiology

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Jul; Vol. 78 (7), pp. 1199-1200. Date of Electronic Publication: 2022 Mar 11.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Deep learning for evaluation of microvascular invasion in hepatocellular carcinoma from tumor areas of histology images.

  • Authors : Chen Q; Department of Gastroenterology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.; Xiao H

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Deep Learning* ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Hepatology international [Hepatol Int] 2022 Jun; Vol. 16 (3), pp. 590-602. Date of Electronic Publication: 2022 Mar 28.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.

  • Authors : Bhagavathula AS; Department of Social and Clinical Pharmacy, Faculty of Pharmacy at Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.; Woolf B

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/epidemiology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/chemically induced ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/epidemiology

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Apr; Vol. 78 (4), pp. 547-555. Date of Electronic Publication: 2022 Jan 18.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  278 results for ""Cohort Studies""